Sergio Dompé

Sergio Gianfranco Luigi Maria Dompé obtained three honorary degrees (pharmaceutical biotechnology from the University of Bologna in 1996, medical biotechnology from the University of L’Aquila in 2005, and pharmacy from the University of Urbino in 2010), as a result of his commitment to the pharmaceutical industry. In 1976, he started working for Dompé Farmaceutici S.p.A., founded by his father in 1940, and right from the start brought many changes to the company’s strategy. He was among the first entrepreneurs in the industry to believe strongly in the opportunities offered by biotechnology for the development of new drugs. On the basis of this intuition, he established partnerships with global pharmaceutical companies to provide patients with new therapeutic benefits. Sergio Dompé holds the office of Chairman of Dompé Farmaceutici S.p.A., the holding company of Dompé Group, which operates through three different companies: Dompé, Amgen Dompé, and Biogen Dompé. It employs 800 persons globally and registered a turnover of 529.4 million Euros in 2010. From 1998 to 2004 Sergio Dompé was Chairman of Assobiotech for three consecutive terms. In June 2005 he was appointed President of Farmindustria, the Italian Pharmaceutical Companies’ Association, and a member of the Confindustria Council. Since January 2006 he has been Chairman of the Assessment Committee of the CNR (Italian Research Council). Since July 2007 he has been a member of the Council of the Italian Institute of Technology foundation.